BLISSGVSBSEBLISS GVS PHARMA LTD· PharmaceuticalsHighPositive
Announced Thu, 1 Oct, 2026 · 09:01 IST

Anupam Rasayan crosses 50% in Bliss GVS, becomes new promoter

Promoter Stake BuyCreeping Acquisition Near ThresholdOwnership Changes View source PDFExplain this filing

BLISSGVS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.8%1-day move
₹691.00
prior close
₹681.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3+1.2+0.3+1.3-3.8-1.2-0.9-3.5——————
Up moveDown movePending
AI summary

Anupam Rasayan India and its PAC Mates Visa Consultancy acquired 5,09,84,595 equity shares (47.95%) of Bliss GVS Pharma through a Share Purchase Agreement on 28 September 2026. Combined with 22,51,669 shares already held from an earlier on-market purchase and the open offer, total holding is 5,32,36,264 shares, or 50.07% of paid-up equity capital. Anupam Rasayan and the PAC have now become promoters and gained control of Bliss GVS Pharma from 28 September 2026.

Likely market impact

Major ownership change as Anupam Rasayan becomes the new promoter and controlling shareholder of Bliss GVS Pharma. Expect board reshuffle and strategic shifts.